Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer . [ 1 ] [ 2 ] Docetaxel has an approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed. more

Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer . [ 1 ] [ 2 ] Docetaxel has an approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed. [ 3 ] Administered as a one-hour infusion every three weeks generally over a ten cycle course, docetaxel is considered better than doxorubicin , paclitaxel and fluorouracil as a cytotoxic antimicrotubule agent. [ 1 ] Docetaxel is marketed worldwide under the name Taxotere by Sanofi-Aventis. [ 4 ] Annual sales approx $2bn. Patent expires in 2010. less